BioCryst Pharmaceuticals
BCRX
BCRX
102 hedge funds and large institutions have $555M invested in BioCryst Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
18% less capital invested
Capital invested by funds: $677M → $555M (-$123M)
Holders
102
Holding in Top 10
3
Calls
$4.45M
Puts
$4.04M
Top Buyers
| 1 | +$37.9M | |
| 2 | +$5.9M | |
| 3 | +$4.99M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.25M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$1.98M |
Top Sellers
| 1 | -$7.98M | |
| 2 | -$3.29M | |
| 3 | -$3.23M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.79M |
| 5 |
Morgan Stanley
New York
|
-$1.98M |